VIRSTA score: Difference between revisions

From IDWiki
(Created page with "== Background == * Score for effectively ruling out infective endocarditis that can be used to triage patients with Staphylococcus aureus bacteremia to transesophageal en...")
 
No edit summary
 
Line 26: Line 26:
|3
|3
|-
|-
|Community or healthcare-associated bacteremia
|Community or healthcare-associated bacteremia (rather than nosocomial)
|2
|2
|-
|-

Latest revision as of 15:32, 15 April 2022

Background

  • Score for effectively ruling out infective endocarditis that can be used to triage patients with Staphylococcus aureus bacteremia to transesophageal endocarditis or not

Criteria

Item Points
Cerebral or peripheral emboli 5
Meningitis 5
Permanent intracardiac device or previous IE 4
Preexisting native valve disease 3
IV drug use 4
Positive culture after 48 hours 3
Community or healthcare-associated bacteremia (rather than nosocomial) 2
Severe sepsis or septic shock 1
C-reactive protein >190 mg/L 1
  • Preexisting native valve disease include any condition classified as medium or high risk1

Interpretation

  • Cutoff ≥3

Further Reading

  • The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect. 2016;72(5):544-53. doi: 10.1016/j.jinf.2016.02.003 The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia

References

  1. ^  Adnan S. Dajani, Kathryn A. Taubert, Walter Wilson, Ann F. Bolger, Arnold Bayer, Patricia Ferrieri, Michael H. Gewitz, Stanford T. Shulman, Soraya Nouri, Jane W. Newburger, Cecilia Hutton, Thomas J. Pallasch, Tommy W. Gage, Matthew E. Levison, Georges Peter, Gregory Zuccaro. Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association. The Journal of the American Dental Association. 1997;128(8):1142-1151. doi:10.14219/jada.archive.1997.0375.